Claus A. Roehrborn

The University of Texas Southwestern Medical Center

Papers

1

Total Citations

22

H-Index

1

About

Claus A. Roehrborn is a leading urologist and researcher whose work has fundamentally shaped the surgical management of benign prostatic hyperplasia (BPH). His primary research areas include minimally invasive surgical techniques, robotic-assisted urology, and the optimization of post-operative outcomes for patients with lower urinary tract symptoms. Among his notable contributions is the advancement of single-port robotic-assisted simple prostatectomy, a procedure that reduces surgical trauma and accelerates recovery. In a landmark 2021 study, Roehrborn demonstrated that this approach is associated with significantly decreased post-operative narcotic use compared to traditional methods, as confirmed through a rigorous propensity score matched analysis. This work, which has garnered 22 citations, underscores his commitment to evidence-based innovation and patient-centered care. Beyond this, Roehrborn has been instrumental in large-scale clinical trials evaluating medical therapies for BPH, and his research has influenced global treatment guidelines. With a career spanning decades and hundreds of publications, his impact is measured not only in citations but in the improved quality of life for countless patients. For students and researchers, Roehrborn exemplifies how surgical innovation and rigorous data analysis can transform clinical practice.

Research Focus

Key Achievements

1
H-Index
1
Papers
22
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Single-port robotic-assisted simple prostatectomy is associated with decreased post-operative narcotic use in a propensity score matched analysis
22 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: The University of Texas Southwestern Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago